TBPH - Theravance Biopharma, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$27.00
DETAILS
HIGH:
$40.00
LOW:
$14.00
MEDIAN:
$27.00
CONSENSUS:
$27.00
UPSIDE:
64.94%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 107.5 | 64.4 | 57.4 | 51.3 | 55.3 | 71.9 | 73.4 | 60.4 | 15.4 | 48.6 | 42.1 | 11.7 | 0.2 | 130.1 | 14.9 |
| Cost of Revenue | 5.5 | 0 | 40.6 | 63.4 | 193.7 | 0 | 0 | 0.7 | 6.0 | 2.9 | 4.7 | 4.1 | 120.6 | 114.0 | 3.8 |
| Gross Profit | 101.9 | 64.4 | 16.8 | (12.0) | (138.3) | 71.9 | 73.4 | 59.7 | 9.4 | 45.8 | 37.5 | 7.6 | (120.4) | 16.1 | 11.0 |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 37.4 | 37.6 | 46.3 | 70.1 | 201.5 | 261.0 | 219.2 | 201.3 | 173.9 | 141.7 | 129.2 | 168.5 | 120.6 | 114.0 | 98.8 |
| SG&A Expenses | 73.7 | 69.2 | 70.5 | 67.1 | 99.3 | 108.5 | 106.1 | 97.1 | 95.6 | 84.5 | 90.2 | 71.6 | 35.9 | 25.7 | 21.5 |
| Other Expenses | 4.1 | 4.5 | (44.0) | (57.2) | (181.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 115.2 | 111.3 | 72.8 | 79.9 | 119.4 | 369.5 | 325.3 | 298.4 | 269.5 | 226.2 | 219.4 | 240.2 | 156.5 | 139.7 | 120.3 |
| Operating Income | |||||||||||||||
| Operating Income | (13.2) | (46.9) | (56.0) | (92.0) | (257.8) | (297.6) | (251.9) | (238.8) | (260.1) | (180.5) | (181.9) | (232.5) | (156.3) | (9.6) | (109.3) |
| Interest Expense | 2.5 | 2.5 | 2.4 | 6.4 | 8.5 | 8.5 | 31.9 | 10.5 | 8.5 | 1.4 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 4.9 | 9.1 | 8.5 | 1.1 | 4.4 | 8.4 | 12.0 | 4.8 | 1.3 | 0.6 | 1.9 | 0 | 0 | 0 |
| Profitability | |||||||||||||||
| EBITDA | (7.7) | (38.5) | (51.6) | (76.1) | (232.8) | (287.8) | (203.6) | (212.4) | (259.1) | (176.0) | (178.8) | (228.0) | (153.6) | (6.3) | (105.5) |
| EBIT | (13.2) | (42.1) | (53.6) | (79.1) | (237.6) | (294.8) | (209.8) | (215.6) | (263.2) | (179.2) | (181.3) | (230.7) | (156.3) | (9.6) | (109.3) |
| Income Before Tax | 129.2 | (44.6) | (49.3) | (92.8) | (265.2) | (303.3) | (241.7) | (226.1) | (271.7) | (180.6) | (181.3) | (230.7) | (156.3) | (9.6) | (109.3) |
| Income Tax Expense | 23.4 | 11.8 | 5.9 | 0.0 | (0.2) | (8.5) | (5.2) | (10.6) | 13.7 | 10.1 | 1.0 | 6.4 | 0 | 0 | 0 |
| Net Income | 105.9 | (56.4) | (55.2) | 872.1 | (199.4) | (278.0) | (236.5) | (215.5) | (285.4) | (190.7) | (182.2) | (237.0) | (156.3) | (9.6) | (109.3) |
| Per Share Data | |||||||||||||||
| EPS (Basic) | 2.10 | -1.15 | -1.00 | -1.26 | -2.87 | -4.46 | -4.25 | -3.99 | -5.45 | -4.26 | -5.34 | -7.46 | -4.92 | -0.30 | -3.43 |
| EPS (Diluted) | 2.06 | -1.15 | -1.00 | -1.26 | -2.87 | -4.46 | -4.25 | -3.99 | -5.45 | -4.26 | -5.34 | -7.46 | -4.84 | -0.30 | -3.43 |
| Shares Outstanding | 50.3 | 48.8 | 55.3 | 73.6 | 69.5 | 62.3 | 55.6 | 54.0 | 52.4 | 44.7 | 34.1 | 31.8 | 31.7 | 31.7 | 31.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 167.8 | 37.8 | 39.5 | 298.2 | 90.0 | 81.5 | 58.1 | 378.0 | 89.0 | 344.7 |
| Short-Term Investments | 147.6 | 50.6 | 62.9 | 29.3 | 83.5 | 211.5 | 222.8 | 127.3 | 259.6 | 156.4 |
| Net Receivables | 95.5 | 68.4 | 17.5 | 16.8 | 57.6 | 69.7 | 50.6 | 10.7 | 9.4 | 9.7 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.8 | 12.2 |
| Other Current Assets | 7.6 | 4.2 | 11.6 | 7.7 | 8.6 | 10.4 | 7.1 | 0 | 3.7 | 2.4 |
| Total Current Assets | 418.5 | 161.1 | 133.5 | 353.5 | 249.9 | 393.3 | 338.5 | 532.8 | 378.7 | 528.5 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 30.3 | 35.8 | 45.4 | 52.0 | 53.3 | 59.7 | 59.2 | 13.2 | 10.2 | 8.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 14.3 | 0 | 0 | 0 | 68.4 | 0.8 | 9.5 | 11.9 | 41.6 | 91.6 |
| Other Non-Current Assets | 22.5 | 157.3 | 203.1 | 201.9 | 3.2 | 15.2 | 1.6 | 2.4 | 10.9 | 10.7 |
| Total Non-Current Assets | 67.1 | 193.1 | 248.5 | 253.9 | 124.9 | 75.7 | 70.3 | 27.4 | 62.7 | 110.8 |
| Total Assets | 485.6 | 354.2 | 382.0 | 607.4 | 374.8 | 469.1 | 408.8 | 560.2 | 441.4 | 639.3 |
| Current Liabilities | ||||||||||
| Account Payables | 2.6 | 2.2 | 1.5 | 1.6 | 3.1 | 6.8 | 4.8 | 9.0 | 5.9 | 1.7 |
| Short-Term Debt | 10.9 | 0 | 0 | 0 | 17.4 | 29.2 | 17.6 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0.0 | 0.1 | 11.5 | 31.6 | 43.4 | 0.1 | 0.2 |
| Other Current Liabilities | 19.5 | 0 | 12.9 | (0.0) | 25.2 | 40.8 | 29.6 | 22.3 | 32.4 | 33.4 |
| Total Current Liabilities | 38.3 | 32.1 | 24.8 | 28.7 | 58.6 | 123.6 | 111.7 | 98.6 | 62.6 | 49.3 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 32.8 | 0 | 0 | 0 | 599.4 | 599.8 | 445.2 | 454.4 | 223.7 | 222.7 |
| Deferred Tax Liabilities | 85.7 | 0 | 0 | 0 | 0.2 | 0 | 0 | (26.2) | 0 | 0 |
| Other Non-Current Liabilities | 0.3 | 107.4 | 99.0 | 91.3 | 2.2 | 1.8 | 21.3 | 32.7 | 39.9 | 17.1 |
| Total Non-Current Liabilities | 150.5 | 146.5 | 144.2 | 136.9 | 654.8 | 649.2 | 521.0 | 513.3 | 263.7 | 239.8 |
| Total Liabilities | 188.8 | 178.6 | 169.0 | 165.6 | 713.4 | 772.8 | 632.7 | 611.8 | 326.2 | 289.0 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (859.6) | (965.5) | (909.1) | (853.9) | (1,726.0) | (1,526.6) | (1,248.6) | (1,012.1) | (797.7) | (512.2) |
| Accumulated Other Comprehensive Income | 0.1 | 0.0 | (0.1) | (0.0) | 0 | 0.0 | 0.1 | (0.2) | (0.7) | (0.3) |
| Total Stockholders' Equity | 296.7 | 175.5 | 213.0 | 441.8 | (338.6) | (303.8) | (223.8) | (51.6) | 115.2 | 350.2 |
| Total Liabilities & Equity | 485.6 | 354.2 | 382.0 | 607.4 | 374.8 | 469.1 | 408.8 | 560.2 | 441.4 | 639.3 |
| Debt Metrics | ||||||||||
| Total Debt | 75.5 | 49.8 | 49.2 | 52.2 | 669.5 | 676.3 | 510.5 | 454.4 | 223.7 | 222.7 |
| Net Debt | (92.3) | 12.0 | 9.6 | (246.0) | 579.6 | 594.8 | 452.5 | 76.3 | 134.8 | (122.0) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 105.9 | (56.4) | (55.2) | (92.8) | (265.1) | (294.8) | (236.5) | (215.5) | (285.4) | (190.7) |
| Depreciation & Amortization | 5.6 | 3.6 | 4.3 | 7.0 | 8.6 | 7.0 | 6.2 | 3.2 | 4.0 | 3.1 |
| Stock-Based Compensation | 18.5 | 21.4 | 25.4 | 39.7 | 62.1 | 63.0 | 60.5 | 51.3 | 49.1 | 41.2 |
| Change in Working Capital | 120.5 | 20.4 | (8.3) | 42.4 | (39.5) | (37.8) | (45.4) | 59.4 | 22.4 | 46.9 |
| Other Non-Cash Items | (0.4) | 7.1 | 3.7 | (183.3) | 26.1 | 12.2 | (23.0) | (0.0) | 0.0 | 0.2 |
| Operating Cash Flow | 238.5 | (11.5) | (27.0) | (187.0) | (207.9) | (250.4) | (238.2) | (112.9) | (201.1) | (99.0) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.0) | (0.3) | (2.5) | (0.6) | (3.4) | (6.6) | (3.2) | (7.2) | (2.4) | (2.1) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 20 | 0 | 0 |
| Purchases of Investments | (248.2) | (143.0) | (134.5) | (103.1) | (158.3) | (402.0) | (423.9) | (183.3) | (288.8) | (237.6) |
| Sales/Maturities of Investments | 143.0 | 155.7 | 102.8 | 158.0 | 286.2 | 419.3 | 339.0 | 347.2 | 234.9 | 91.5 |
| Other Investing Activities | 0 | 0 | 1.5 | 1,099.7 | 0.0 | 0.1 | 0.0 | 0.0 | (53.9) | (146.1) |
| Investing Cash Flow | (105.3) | 12.3 | (32.7) | 1,154.0 | 124.5 | 10.7 | (83.1) | 176.7 | (56.3) | (148.2) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | (631.6) | (10.7) | 144.7 | (2.2) | 229.4 | 0 | 222.5 |
| Stock Repurchased | (4.0) | (3.1) | (199.6) | (132.3) | (9.1) | (9.7) | (3.2) | (9.8) | (8.6) | (3.9) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0.5 | 0.6 | 5.1 | 3.5 | (11.7) | 6.6 | 5.6 | 10.2 | 7.6 |
| Financing Cash Flow | (3.2) | (2.5) | (198.9) | (758.8) | 91.9 | 263.1 | 1.3 | 225.2 | 1.7 | 479.2 |
| Cash Position | ||||||||||
| Net Change in Cash | 130.0 | (1.7) | (258.6) | 208.2 | 8.5 | 23.4 | (320.0) | 289.0 | (255.7) | 232.0 |
| Cash at Beginning | 38.6 | 40.4 | 299.0 | 90.8 | 82.3 | 58.9 | 378.9 | 89.8 | 344.7 | 112.7 |
| Cash at End | 168.6 | 38.6 | 40.4 | 299.0 | 90.8 | 82.3 | 58.9 | 378.9 | 89.0 | 344.7 |
| Free Cash Flow | 238.5 | (11.9) | (29.5) | (187.6) | (211.3) | (257.0) | (241.4) | (120.1) | (203.5) | (101.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 107.5 | 64.4 | 57.4 | 51.3 | 55.3 | 71.9 | 73.4 | 60.4 | 15.4 | 48.6 | 42.1 | 11.7 | 0.2 | 130.1 | 14.9 |
| Gross Profit | 101.9 | 64.4 | 16.8 | (12.0) | (138.3) | 71.9 | 73.4 | 59.7 | 9.4 | 45.8 | 37.5 | 7.6 | (120.4) | 16.1 | 11.0 |
| Operating Income | (13.2) | (46.9) | (56.0) | (92.0) | (257.8) | (297.6) | (251.9) | (238.8) | (260.1) | (180.5) | (181.9) | (232.5) | (156.3) | (9.6) | (109.3) |
| Net Income | 105.9 | (56.4) | (55.2) | 872.1 | (199.4) | (278.0) | (236.5) | (215.5) | (285.4) | (190.7) | (182.2) | (237.0) | (156.3) | (9.6) | (109.3) |
| EPS (Diluted) | 2.06 | -1.15 | -1.00 | -1.26 | -2.87 | -4.46 | -4.25 | -3.99 | -5.45 | -4.26 | -5.34 | -7.46 | -4.84 | -0.30 | -3.43 |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 167.8 | 37.8 | 39.5 | 298.2 | 90.0 | 81.5 | 58.1 | 378.0 | 89.0 | 344.7 | |||||
| Total Assets | 485.6 | 354.2 | 382.0 | 607.4 | 374.8 | 469.1 | 408.8 | 560.2 | 441.4 | 639.3 | |||||
| Total Debt | 75.5 | 49.8 | 49.2 | 52.2 | 669.5 | 676.3 | 510.5 | 454.4 | 223.7 | 222.7 | |||||
| Stockholders' Equity | 296.7 | 175.5 | 213.0 | 441.8 | (338.6) | (303.8) | (223.8) | (51.6) | 115.2 | 350.2 | |||||
| Cash Flow | |||||||||||||||
| Operating Cash Flow | 238.5 | (11.5) | (27.0) | (187.0) | (207.9) | (250.4) | (238.2) | (112.9) | (201.1) | (99.0) | |||||
| Capital Expenditure | (0.0) | (0.3) | (2.5) | (0.6) | (3.4) | (6.6) | (3.2) | (7.2) | (2.4) | (2.1) | |||||
| Free Cash Flow | 238.5 | (11.9) | (29.5) | (187.6) | (211.3) | (257.0) | (241.4) | (120.1) | (203.5) | (101.1) | |||||